A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

The purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or more standard of care treatments.

This study has been completed.

To Learn More Contact
Study Contact at 844-434-4210 or JNT.CT@sylogent.com
ClinicalTrials.gov identifier: NCT03517722.

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up